Skip to main content
Equibles

UBS Group AG

Position in EOCN — Galmed Pharmaceuticals Ltd.

CIK 1610520 ZURICH, V8
Back to EOCN Full portfolio

Position in EOCN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2
+$2 QoQ
Shares Held
3
-99.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 12 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EOCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. EOCN ranks #550 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in EOCN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2 3
2026-03-31 — 2,546
2025-12-31 — 1,814
2025-09-30 — 963
2025-06-30 — 6,903
2025-03-31 — 1,104
2024-12-31 — 6,721
2024-09-30 — 5,267
2024-06-30 — 280
2024-03-31 — 2,260
2023-09-30 — 28
2023-06-30 — 1
2023-03-31 — 4,307
2022-12-31 — 21,432
2022-09-30 — 26,986
2022-06-30 — 6,064
2021-12-31 — 6,356
2021-09-30 — 160
2021-03-31 — 3,418
2020-12-31 — 10,309
2020-06-30 — 633
2020-03-31 — 3,500